Key Takeaways
- • LongueVue Capital and Swaney Group Capital have jointly acquired Apex Dental Laboratory Group, a 16-location, 400-employee dental lab platform headquartered in Waco, Texas, with all manufacturing operations based domestically—a competitive differentiation in an industry increasingly reliant on offshore outsourcing.
- • Apex operates a scaled acquisition platform built through 22 acquisitions and three de novo openings since 2015, positioning itself to consolidate a highly fragmented U.S. dental laboratory market valued at $7.6 billion with 4,375 competitors and facing structural consolidation pressures from dental service organizations (DSOs).
- • Bill Braun, former CEO and president of DDS Lab, has joined LongueVue as operating partner and executive chairman of Apex, bringing operational expertise to accelerate growth and strengthen the company's competitive positioning as a national platform.
- • The global dental laboratories market is projected to expand from $24.3 billion in 2025 to $40.8 billion by 2033 (6.8% CAGR), driven by demand for restorative and cosmetic procedures and adoption of CAD/CAM and 3D-printing technologies—providing tailwinds for scaled, technology-enabled platforms.
- • Abacus Finance provided senior secured credit facilities and made an equity co-investment, leveraging its recently closed $262.5 million SBIC vehicle to support the transaction.
Summary
LongueVue Capital, a New Orleans-based middle-market private equity firm with more than $800 million in committed capital across five funds, has partnered with Swaney Group Capital to acquire Apex Dental Laboratory Group. The transaction represents a significant consolidation play in a fragmented $7.6 billion U.S. dental laboratory industry characterized by 4,375 operating businesses and mounting pressure from centralized dental service organizations demanding scaled, technology-enabled platforms.
Apex operates 16 dental laboratories across 12 states and employs approximately 400 people. The platform distinguishes itself through a commitment to domestic manufacturing—a deliberate competitive positioning as the industry increasingly turns to offshore outsourcing. The company's brand portfolio includes Kinder Krowns (3D-printed pediatric crowns), Snap-On Smile and Lumineers (cosmetic veneers), and SurgicalGuides.com, positioning it as a differentiated regional competitor. Founded in 2015 by Kay Hayden, who remains co-founder and president, Apex built its national footprint through 22 acquisitions and three de novo laboratory openings, establishing itself as an acquisition platform that allows founding operators to retain local brand identity and customer relationships while accessing Apex's national infrastructure.
Ryan Nagim, managing partner at LongueVue and head of healthcare, characterized the acquisition as a strategic fit aligned with the firm's focus on healthcare businesses delivering value to patients and providers. Bill Braun, former CEO and president of DDS Lab, has joined LongueVue as operating partner and assumed the executive chairman role at Apex, bringing operational expertise from managing one of the nation's largest dental laboratory platforms. Paul Swaney, managing partner of Swaney Group (founded 2022, headquartered in St. Petersburg, Florida), emphasized the firm's operational improvement model and hands-on approach, positioning the partnership as capable of scaling Apex through organic growth, technology investment, and strategic acquisitions while driving operational efficiency.
The transaction is supported by senior secured credit facilities arranged by Abacus Finance, which also made an equity co-investment. Abacus, which closed its first Small Business Investment Company vehicle in October 2025 at $262.5 million, specializes in sponsor-led transactions in the lower middle market. The acquisition aligns with broader industry growth dynamics: the global dental laboratories market was valued at $24.3 billion in 2025 and is projected to reach $40.8 billion by 2033 at a 6.8% compound annual growth rate, driven by rising demand for restorative and cosmetic procedures and rapid adoption of CAD/CAM and 3D-printing technologies. Brown Gibbons Lang served as financial advisor to Apex on the transaction.
Apex operates 16 dental laboratories across 12 states and employs approximately 400 people. The platform distinguishes itself through a commitment to domestic manufacturing—a deliberate competitive positioning as the industry increasingly turns to offshore outsourcing. The company's brand portfolio includes Kinder Krowns (3D-printed pediatric crowns), Snap-On Smile and Lumineers (cosmetic veneers), and SurgicalGuides.com, positioning it as a differentiated regional competitor. Founded in 2015 by Kay Hayden, who remains co-founder and president, Apex built its national footprint through 22 acquisitions and three de novo laboratory openings, establishing itself as an acquisition platform that allows founding operators to retain local brand identity and customer relationships while accessing Apex's national infrastructure.
Ryan Nagim, managing partner at LongueVue and head of healthcare, characterized the acquisition as a strategic fit aligned with the firm's focus on healthcare businesses delivering value to patients and providers. Bill Braun, former CEO and president of DDS Lab, has joined LongueVue as operating partner and assumed the executive chairman role at Apex, bringing operational expertise from managing one of the nation's largest dental laboratory platforms. Paul Swaney, managing partner of Swaney Group (founded 2022, headquartered in St. Petersburg, Florida), emphasized the firm's operational improvement model and hands-on approach, positioning the partnership as capable of scaling Apex through organic growth, technology investment, and strategic acquisitions while driving operational efficiency.
The transaction is supported by senior secured credit facilities arranged by Abacus Finance, which also made an equity co-investment. Abacus, which closed its first Small Business Investment Company vehicle in October 2025 at $262.5 million, specializes in sponsor-led transactions in the lower middle market. The acquisition aligns with broader industry growth dynamics: the global dental laboratories market was valued at $24.3 billion in 2025 and is projected to reach $40.8 billion by 2033 at a 6.8% compound annual growth rate, driven by rising demand for restorative and cosmetic procedures and rapid adoption of CAD/CAM and 3D-printing technologies. Brown Gibbons Lang served as financial advisor to Apex on the transaction.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.